![](/img/cover-not-exists.png)
WEE1 kinase inhibitor AZD1775 has pre-clinical efficacy in LKB1-deficient non-small cell lung cancer
Richer, Amanda L, Cala, Jacqueline M, O'Brien, Kelley, Carson, Vashti M, Inge, Landon J., Whitsett, Timothy GLanguage:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-16-3565
Date:
June, 2017
File:
PDF, 13.71 MB
english, 2017